Suppression of frequently recurring genital herpes: acyclovir v inosine pranobex
- PMID: 2473952
- PMCID: PMC1194297
- DOI: 10.1136/sti.65.2.103
Suppression of frequently recurring genital herpes: acyclovir v inosine pranobex
Abstract
The suppressive action of acyclovir and inosine pranobex was compared in a randomised double blind controlled trial in patients with frequently recurring genital herpes. Fourteen patients received acyclovir and 17 inosine pranobex. Treatment continued for 12 weeks. The time to the first recurrence was significantly longer and the frequency of recurrences significantly less in the recipients of acyclovir. No important side effects were noted. It is concluded that acyclovir is the treatment of choice to suppress often recurring genital herpes.
Similar articles
-
Treatment of first-attack genital herpes--acyclovir versus inosine pranobex.Lancet. 1987 May 23;1(8543):1171-3. doi: 10.1016/s0140-6736(87)92144-1. Lancet. 1987. PMID: 2437417 Clinical Trial.
-
Comparative studies of inosine pranobex and acyclovir.Am J Med. 1988 Aug 29;85(2A):7-9. Am J Med. 1988. PMID: 2457315 Clinical Trial.
-
Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients.J Dermatol. 2015 Jun;42(6):596-601. doi: 10.1111/1346-8138.12845. Epub 2015 Mar 26. J Dermatol. 2015. PMID: 25819042 Clinical Trial.
-
Genital herpes - the disease and its treatment including intravenous acyclovir.J Antimicrob Chemother. 1983 Sep;12 Suppl B:51-9. doi: 10.1093/jac/12.suppl_b.51. J Antimicrob Chemother. 1983. PMID: 6355051 Review.
-
Topical acyclovir in the treatment of genital herpes: a comparison with systemic therapy.J Antimicrob Chemother. 1983 Sep;12 Suppl B:67-77. doi: 10.1093/jac/12.suppl_b.67. J Antimicrob Chemother. 1983. PMID: 6355053 Review.
Cited by
-
Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.Cochrane Database Syst Rev. 2014 Aug 3;2014(8):CD009036. doi: 10.1002/14651858.CD009036.pub2. Cochrane Database Syst Rev. 2014. PMID: 25086573 Free PMC article.
-
Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course.Viruses. 2021 Nov 9;13(11):2246. doi: 10.3390/v13112246. Viruses. 2021. PMID: 34835052 Free PMC article. Review.
-
Acyclovir vs isoprinosine (immunovir) for suppression of recurrent genital herpes simplex infection.Genitourin Med. 1992 Oct;68(5):312-6. doi: 10.1136/sti.68.5.312. Genitourin Med. 1992. PMID: 1385295 Free PMC article. Clinical Trial.
-
Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases.Adv Ther. 2019 Aug;36(8):1878-1905. doi: 10.1007/s12325-019-00995-6. Epub 2019 Jun 5. Adv Ther. 2019. PMID: 31168764 Free PMC article. Review.
-
Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.Drugs. 1994 Jan;47(1):153-205. doi: 10.2165/00003495-199447010-00009. Drugs. 1994. PMID: 7510619 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical